Researchers have reviewed the interplay between cellular senescence and mitochondrial dysfunction in the aging of the vascular endothelium, highlighting their roles in vascular health decline. The vascular endothelium, which lines blood vessels, is crucial for regulating inflammatory responses, vascular tone, and angiogenesis. As endothelial cells age, they accumulate senescent cells and experience mitochondrial dysfunction, both of which contribute to a range of vascular issues, including atherosclerosis and impaired blood-brain barrier integrity.

The review emphasizes that mitochondrial dysfunction accelerates cellular senescence, creating a feedback loop that exacerbates endothelial decline. Key findings indicate that age-related alterations in endothelial metabolism lead to reduced nitric oxide bioavailability, increased oxidative stress, and impaired vasodilatory capacity. These changes stem from shifts in energy production and redox signaling, ultimately undermining endothelial homeostasis. Senescent endothelial cells not only reflect the burden of metabolic stress but also propagate dysfunction through chronic inflammation and oxidative stress, further accelerating vascular aging.

This synthesis of current evidence positions mitochondrial metabolism as a critical, yet underexplored, therapeutic target for age-related vascular dysfunction. By focusing on mitochondrial impairment and its contributions to endothelial aging, this review suggests new avenues for intervention that could potentially delay or reverse vascular aging processes. Targeting mitochondrial dysfunction may provide a strategic approach to enhance endothelial resilience and improve overall vascular health, shifting current research paradigms towards metabolic reprogramming as a viable therapeutic strategy in combating age-associated vascular diseases.

Source: fightaging.org